TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Infectex initiates enrollment in SQ109 Phase IIb-III trial for MDR-TB

Sequella
Dec. 21, 2012, 10:27 p.m.
post image

The trial will compare the effects of an optimized background drug regimen alone with an optimized background regimen plus SQ109 in MDR-TB patients.

Read the press release here.


Source: Sequella